PMC:1626108 / 44596-45188 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T8703 0-6 NN denotes Rabbit
T8704 7-15 NNS denotes antisera
T8706 16-20 VBD denotes were
T8705 21-27 VBN denotes raised
T8707 28-35 IN denotes against
T8708 36-39 DT denotes the
T8710 40-51 JJ denotes recombinant
T8711 52-58 JJ denotes murine
T8709 59-64 NN denotes Cox11
T8712 65-66 -LRB- denotes (
T8714 66-74 NNS denotes residues
T8713 75-77 CD denotes 40
T8715 77-78 SYM denotes
T8716 78-81 CD denotes 275
T8717 81-82 -RRB- denotes )
T8718 83-86 CC denotes and
T8719 87-95 NN denotes affinity
T8721 95-96 HYPH denotes -
T8720 96-104 VBN denotes purified
T8722 105-110 IN denotes under
T8723 111-125 NN denotes non-denaturing
T8724 126-136 NNS denotes conditions
T8725 137-138 -LRB- denotes (
T8726 138-148 NNP denotes Stereogene
T8727 148-149 -RRB- denotes )
T8728 150-152 IN denotes as
T8730 153-163 RB denotes previously
T8729 164-173 VBN denotes described
T8731 174-175 -LRB- denotes [
T8732 175-177 CD denotes 13
T8733 177-178 -RRB- denotes ]
T8734 178-179 . denotes .
T8735 179-241 sentence denotes Cox11 antibodies were used at 200 ng/ml for Western analysis.
T8736 180-185 NN denotes Cox11
T8737 186-196 NNS denotes antibodies
T8739 197-201 VBD denotes were
T8738 202-206 VBN denotes used
T8740 207-209 IN denotes at
T8741 210-213 CD denotes 200
T8742 214-216 NNS denotes ng
T8743 216-217 SYM denotes /
T8744 217-219 NN denotes ml
T8745 220-223 IN denotes for
T8746 224-231 NNP denotes Western
T8747 232-240 NN denotes analysis
T8748 240-241 . denotes .
T8749 241-427 sentence denotes The monoclonal antibody Hsp70 was from Affinity Bioreagents (Golden, Colorado, United States) and antibodies against the KBD (JX2) and ZnF domains of RanBP2 have been described [13,16].
T8750 242-245 DT denotes The
T8752 246-256 JJ denotes monoclonal
T8753 257-265 NN denotes antibody
T8751 266-271 NN denotes Hsp70
T8754 272-275 VBD denotes was
T8755 276-280 IN denotes from
T8756 281-289 NNP denotes Affinity
T8757 290-301 NNPS denotes Bioreagents
T8758 302-303 -LRB- denotes (
T8759 303-309 NNP denotes Golden
T8760 309-311 , denotes ,
T8761 311-319 NNP denotes Colorado
T8762 319-321 , denotes ,
T8763 321-327 NNP denotes United
T8764 328-334 NNP denotes States
T8765 334-335 -RRB- denotes )
T8766 336-339 CC denotes and
T8767 340-350 NNS denotes antibodies
T8769 351-358 IN denotes against
T8770 359-362 DT denotes the
T8772 363-366 NN denotes KBD
T8773 367-368 -LRB- denotes (
T8774 368-371 NN denotes JX2
T8775 371-372 -RRB- denotes )
T8776 373-376 CC denotes and
T8777 377-380 NN denotes ZnF
T8771 381-388 NNS denotes domains
T8778 389-391 IN denotes of
T8779 392-398 NN denotes RanBP2
T8780 399-403 VBP denotes have
T8781 404-408 VBN denotes been
T8768 409-418 VBN denotes described
T8782 419-420 -LRB- denotes [
T8784 420-422 CD denotes 13
T8785 422-423 , denotes ,
T8783 423-425 CD denotes 16
T8786 425-426 -RRB- denotes ]
T8787 426-427 . denotes .
T8788 427-513 sentence denotes Polyclonal and monoclonal antibodies against Hexokinase I were provided by J. Wilson.
T8789 428-438 JJ denotes Polyclonal
T8791 439-442 CC denotes and
T8792 443-453 JJ denotes monoclonal
T8790 454-464 NNS denotes antibodies
T8794 465-472 IN denotes against
T8795 473-483 NN denotes Hexokinase
T8796 484-485 PRP denotes I
T8797 486-490 VBD denotes were
T8793 491-499 VBN denotes provided
T8798 500-502 IN denotes by
T8799 503-505 NNP denotes J.
T8800 506-512 NNP denotes Wilson
T8801 512-513 . denotes .
T8802 513-592 sentence denotes The mAb414 was purchased from Abcam (Cambridge, Massachusetts, United States).
T8803 514-517 DT denotes The
T8804 518-524 NN denotes mAb414
T8806 525-528 VBD denotes was
T8805 529-538 VBN denotes purchased
T8807 539-543 IN denotes from
T8808 544-549 NNP denotes Abcam
T8809 550-551 -LRB- denotes (
T8810 551-560 NNP denotes Cambridge
T8811 560-562 , denotes ,
T8812 562-575 NNP denotes Massachusetts
T8813 575-577 , denotes ,
T8814 577-583 NNP denotes United
T8815 584-590 NNP denotes States
T8816 590-591 -RRB- denotes )
T8817 591-592 . denotes .
R5728 T8703 T8704 compound Rabbit,antisera
R5729 T8704 T8705 nsubjpass antisera,raised
R5730 T8706 T8705 auxpass were,raised
R5731 T8707 T8705 prep against,raised
R5732 T8708 T8709 det the,Cox11
R5733 T8709 T8707 pobj Cox11,against
R5734 T8710 T8709 amod recombinant,Cox11
R5735 T8711 T8709 amod murine,Cox11
R5736 T8712 T8713 punct (,40
R5737 T8713 T8707 parataxis 40,against
R5738 T8714 T8713 nmod residues,40
R5739 T8715 T8716 punct –,275
R5740 T8716 T8713 prep 275,40
R5741 T8717 T8713 punct ),40
R5742 T8718 T8705 cc and,raised
R5743 T8719 T8720 dep affinity,purified
R5744 T8720 T8705 conj purified,raised
R5745 T8721 T8720 punct -,purified
R5746 T8722 T8720 prep under,purified
R5747 T8723 T8724 compound non-denaturing,conditions
R5748 T8724 T8722 pobj conditions,under
R5749 T8725 T8726 punct (,Stereogene
R5750 T8726 T8724 parataxis Stereogene,conditions
R5751 T8727 T8726 punct ),Stereogene
R5752 T8728 T8729 mark as,described
R5753 T8729 T8720 advcl described,purified
R5754 T8730 T8729 advmod previously,described
R5755 T8731 T8732 punct [,13
R5756 T8732 T8729 parataxis 13,described
R5757 T8733 T8732 punct ],13
R5758 T8734 T8705 punct .,raised
R5759 T8736 T8737 compound Cox11,antibodies
R5760 T8737 T8738 nsubjpass antibodies,used
R5761 T8739 T8738 auxpass were,used
R5762 T8740 T8738 prep at,used
R5763 T8741 T8742 nummod 200,ng
R5764 T8742 T8740 pobj ng,at
R5765 T8743 T8744 punct /,ml
R5766 T8744 T8742 prep ml,ng
R5767 T8745 T8738 prep for,used
R5768 T8746 T8747 compound Western,analysis
R5769 T8747 T8745 pobj analysis,for
R5770 T8748 T8738 punct .,used
R5771 T8750 T8751 det The,Hsp70
R5772 T8751 T8754 nsubj Hsp70,was
R5773 T8752 T8751 amod monoclonal,Hsp70
R5774 T8753 T8751 compound antibody,Hsp70
R5775 T8755 T8754 prep from,was
R5776 T8756 T8757 compound Affinity,Bioreagents
R5777 T8757 T8755 pobj Bioreagents,from
R5778 T8758 T8759 punct (,Golden
R5779 T8759 T8757 parataxis Golden,Bioreagents
R5780 T8760 T8759 punct ", ",Golden
R5781 T8761 T8759 npadvmod Colorado,Golden
R5782 T8762 T8759 punct ", ",Golden
R5783 T8763 T8764 compound United,States
R5784 T8764 T8759 npadvmod States,Golden
R5785 T8765 T8759 punct ),Golden
R5786 T8766 T8754 cc and,was
R5787 T8767 T8768 nsubjpass antibodies,described
R5788 T8768 T8754 conj described,was
R5789 T8769 T8767 prep against,antibodies
R5790 T8770 T8771 det the,domains
R5791 T8771 T8769 pobj domains,against
R5792 T8772 T8771 nmod KBD,domains
R5793 T8773 T8774 punct (,JX2
R5794 T8774 T8772 parataxis JX2,KBD
R5795 T8775 T8774 punct ),JX2
R5796 T8776 T8772 cc and,KBD
R5797 T8777 T8772 conj ZnF,KBD
R5798 T8778 T8771 prep of,domains
R5799 T8779 T8778 pobj RanBP2,of
R5800 T8780 T8768 aux have,described
R5801 T8781 T8768 auxpass been,described
R5802 T8782 T8783 punct [,16
R5803 T8783 T8768 parataxis 16,described
R5804 T8784 T8783 nummod 13,16
R5805 T8785 T8783 punct ",",16
R5806 T8786 T8783 punct ],16
R5807 T8787 T8768 punct .,described
R5808 T8789 T8790 amod Polyclonal,antibodies
R5809 T8790 T8793 nsubjpass antibodies,provided
R5810 T8791 T8789 cc and,Polyclonal
R5811 T8792 T8789 conj monoclonal,Polyclonal
R5812 T8794 T8790 prep against,antibodies
R5813 T8795 T8794 pobj Hexokinase,against
R5814 T8796 T8795 nmod I,Hexokinase
R5815 T8797 T8793 auxpass were,provided
R5816 T8798 T8793 agent by,provided
R5817 T8799 T8800 compound J.,Wilson
R5818 T8800 T8798 pobj Wilson,by
R5819 T8801 T8793 punct .,provided
R5820 T8803 T8804 det The,mAb414
R5821 T8804 T8805 nsubjpass mAb414,purchased
R5822 T8806 T8805 auxpass was,purchased
R5823 T8807 T8805 prep from,purchased
R5824 T8808 T8807 pobj Abcam,from
R5825 T8809 T8810 punct (,Cambridge
R5826 T8810 T8808 parataxis Cambridge,Abcam
R5827 T8811 T8810 punct ", ",Cambridge
R5828 T8812 T8810 npadvmod Massachusetts,Cambridge
R5829 T8813 T8810 punct ", ",Cambridge
R5830 T8814 T8815 compound United,States
R5831 T8815 T8810 npadvmod States,Cambridge
R5832 T8816 T8810 punct ),Cambridge
R5833 T8817 T8805 punct .,purchased